Snapshot Highlights
- Medical Director & Co-Managing Director at MedAustron Ion Therapy Center
- Over three decades of experience in Radiation Oncology and Particle Therapy
- Pioneered Particle Therapy for various diseases into routine clinical practice
- Former Professor at Dartmouth Medical School and University of Zurich
- President of the Particle Therapy Co-Operative Group (PTCOG)
Prof. Dr. Eugen B. Hug
Prof. Dr. Eugen B. Hug is a distinguished leader in Radiation Oncology, currently serving as the Medical Director and Co-Managing Director at the MedAustron Ion Therapy Center in Wiener Neustadt, Austria. His career, commencing in the early 1990s after completing his residency at Massachusetts General Hospital, has been dedicated to advancing and implementing Particle Therapy across a spectrum of diseases. He holds a profound expertise in pediatric malignancies, skull base tumors, and sarcomas, leveraging his extensive experience in proton-radiation therapy.
Professional Journey in Particle Therapy
Dr. Hug’s impactful career includes significant leadership roles in the field of particle therapy. He previously served as the Director of the Paul Scherrer Proton Institute in Switzerland, where he also held the esteemed position of Professor of Proton-Radiation at the University of Zurich. His contributions extended to Dartmouth Medical School as a Professor of Radiation Oncology and Pediatrics, and he held the role of Chief Medical Officer for ProCure, overseeing four proton centers in the United States. Earlier in his career, he was an Associate Professor at Loma Linda University Medical Center and a Staff Member and Lead in Pediatric Radiation Oncology at Massachusetts General Hospital.
Academic and Organizational Leadership
A highly respected figure, Prof. Hug has significantly influenced the global understanding and practice of particle therapy through his academic and organizational leadership. He has held professorships at prestigious institutions such as Dartmouth Medical School and the University of Zurich, educating future generations of oncologists. His commitment to advancing the field is evident in his leadership as President of the Particle Therapy Co-Operative Group (PTCOG) and as a Co-Founder and Past-President of PTCOG North America. He has also been instrumental in establishing educational initiatives like the Paul Scherrer Institute Winter School for Protons and the ESTRO Teaching Course.
Specialized Clinical Focus
Prof. Hug’s clinical practice is distinguished by his focus on complex oncological cases, particularly in pediatric oncology, skull base tumors, and sarcomas. His deep understanding of radiation medicine, combined with his pioneering work in particle therapy, positions him as a leading expert in delivering advanced and precise cancer treatments.